Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism

Human Genetics
|January 1, 1983
PubMed

Insights

Idiopathic haemochromatosis can affect young individuals, with males and females equally impacted. Early diagnosis of this juvenile form is crucial to prevent early death from cardiac issues.

Area of Science:

  • Endocrinology
  • Genetics
  • Cardiology

Background:

  • Idiopathic haemochromatosis is typically considered a disease of middle-aged men.
  • The juvenile form of the disease presents distinct characteristics and challenges.

Observation:

  • Four cases of idiopathic haemochromatosis with onset before age 20 are presented.
  • This juvenile form affects males and females equally.
  • Symptoms include unexplained abdominal pain and hypogonadotropic hypogonadism.

Findings:

  • Juvenile idiopathic haemochromatosis can lead to early mortality due to cardiac dysfunction if untreated.
  • The clinical course resembles that of well-transfused thalassemia major.
  • Early diagnosis is critical for improved outcomes.

Implications:

  • Screening for elevated body iron stores is recommended for young individuals with hypogonadotropic hypogonadism or cardiac dysfunction.
  • This approach can facilitate earlier diagnosis and intervention for the juvenile form of idiopathic haemochromatosis.
  • Understanding the juvenile presentation is vital for pediatric and adult endocrinologists and cardiologists.

Related Concept Videos

Sex-linked Disorders01:43

Sex-linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...